Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans

ABSTRACT: Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans

PROVIDER: PRJNA494239 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans [phase I]

Project description:Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans [phase I]

| PRJNA494240 | ENA

Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans [phase II]

Project description:Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans [phase II]

| PRJNA494241 | ENA

Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans [phase II]

Project description:We performed an experiment in humans, in which broad spectrum antibiotics were administered to healthy young adults, prior and subsequent to vaccination with the seasonal influenza vaccine. Transcriptional profiling of peripheral blood mononuclear cells was performed prior to the vaccination and as a time course following the vaccine administration.

2019-09-05 | GSE120718 | GEO

Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans [phase I]

2019-09-05 | GSE120717 | GEO

Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans

Project description:This SuperSeries is composed of the SubSeries listed below.

2019-09-05 | GSE120719 | GEO

CHIKV VLP Vaccination in Humans induced broadly neutralizing antibodies

Project description:VLP Vaccination in humans induced antigen-specific B cells with broad reactivity and protection in mouse models of infection

2023-03-31 | GSE218843 | GEO

Metabolic Phenotypes of Response to Vaccination in Humans.

Project description: Not available

| S-EPMC5711477 | biostudies-literature

Systems biology of vaccination for seasonal influenza in humans

Project description:Systems biology of vaccination for seasonal influenza in humans

| PRJNA141363 | ENA

Beneficial effect of ACI-24 vaccination on microglial phenotypes in an amyloidosis mouse model

Project description:Amyloid-beta (Aβ) deposition is an initiating factor in Alzheimer´s disease (AD). Microglia are the brain immune cells that surround and phagocytose Aβ, but their phagocytic capacity declines in AD. This is in agreement with studies that associate AD risk loci with genes regulating phagocytic function. Immunotherapies are currently pursued as therapeutic strategies against AD and there are increased efforts to understand the role of the immune system in ameliorating AD pathology. Here, we evaluated the effect of the Aβ targeting ACI-24 vaccine in preventing the AD pathology in an amyloidosis mouse model. ACI-24 vaccination elicited a robust and sustained antibody response in APPPS1 mice with an accompanying reduction of Aβ plaque load, amyloid plaque-associated ApoE and dystrophic neurites as compared to non-vaccinated controls. Furthermore, plaque-associated microglia had the tendency to be more activated post vaccination. The lower Aβ plaque load triggered by vaccination with ACI-24 was in concordance with the bulk transcriptomic analysis that revealed a reduction in the expression of several disease-associated microglial signatures. Accordingly, plaque-distant microglia displayed a more ramified morphology, supporting beneficial effects of the vaccination on bulk microglial phenotypes. Our study demonstrates that administration of the Aβ targeting vaccine, ACI-24, triggers protective microglial responses that translate into a reduction of AD pathology suggesting its use as a safe and cost effective AD therapeutic intervention.

2023-01-09 | PXD038665 | Pride

Global analyses of human immune variation reveal baseline predictors of the post-vaccination response.

Project description:A major goal of systems biology is the development of models that accurately predict responses of a cell or organism to perturbation. Constructing such models requires collection of dense measurements of system states, yet transformation of the data into predictive constructs remains a challenge. As a first step towards modeling human immunity, we have analyzed immune parameters in depth both at baseline and in response to perturbation with influenza vaccination. Peripheral blood cell transcriptomes, serum titers, frequencies of 126 cell subpopulations, and B cell responses were assessed before and after vaccination in 63 individuals and used to develop a systematic, computational framework to dissect inter- and intra-individual variation and build predictive models of post-vaccination antibody responses. Strikingly, independent of age and pre-existing antibody titers, accurate models could be constructed using pre-perturbation parameters alone, which were validated using data from independent baseline time-points. Most of the parameters contributing to prediction delineated temporally-stable baseline differences across individuals, raising the prospect of immune responsiveness prediction before intervention. According to CHI protocol 09-H1-0239, PBMC samples from 63 healthy voluntiers were collected 7 days prior to vaccination, immediately before vaccination (day0), and at 3 time points (day1, day7 and day70) post vaccination. The CHI Consortium

2014-04-10 | E-GEOD-47353 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data